Samasca G, Lerner A. Celiac disease in the COVID-19 pandemic.
J Transl Autoimmun 2021;
4:100120. [PMID:
34485888 PMCID:
PMC8406545 DOI:
10.1016/j.jtauto.2021.100120]
[Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2021] [Accepted: 08/30/2021] [Indexed: 12/19/2022] Open
Abstract
Background
The COVID-19 pandemic has had an impact on global health.
Design
The impact of the COVID-19 pandemic on patients with coeliac disease was assessed in the present review.
Results
The incidence of coeliac disease and the problems associated with coeliac disease increased during the COVID-19 pandemic. Adherence to the diet is crucial for the patient's health and quality of life since the only approved therapy for coeliac disease is a gluten withdrawal.
Conclusions
A gluten-free diet should be promoted by the therapeutic team and implemented among these categories of patients.
Health education to follow the GFD does not exist in many countries. Unfortunately, the COVID-19 pandemic has increased psychological problems among patients with CD.
The association of T1D with CD has been and remains a problem in CD management.
Associating IBD with CD is again a challenge. Psychological problems also appeared in the associations of CD with T1D and IBD. The COVID-19 virus did not pose an increased risk to CD patients, but the COVID-19 pandemic brought many psychological problems to CD patients.
CD patients should adhere to GFD, in general, hence pay attention to gluten withdrawal during the COVID-19 pandemics, to avoid other complications and improve their QOL.
Collapse